Actively Recruiting
The Allergen Reduction and Child Health Study (ARCHS)
Led by Tulane University · Updated on 2025-09-09
290
Participants Needed
1
Research Sites
389 weeks
Total Duration
On this page
Sponsors
T
Tulane University
Lead Sponsor
P
Patient-Centered Outcomes Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
The Allergen Reduction and Child Health Study (ARCHS) is a 12-month, two group randomized control trial of children with asthma and who are exposed to cockroaches. Children ages 5 - 17 living in the Greater New Orleans area will be recruited from a variety of clinic and community settings. The overall goal of the study is to improve patient-centered asthma outcomes (asthma symptom days, health care utilization, asthma control and quality of life) by targeting one key allergen - cockroach exposure in the child's home. The investigators propose a simple intervention of insecticidal bait that is low cost, simple to implement, and which is lower toxicity than other forms of pest control. The reduction in the number of cockroaches in the home is an environmental outcome that is patient-centered and is likely to add to its acceptance by families of children with asthma.
CONDITIONS
Official Title
The Allergen Reduction and Child Health Study (ARCHS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 5 to 17 years
- Uncontrolled persistent asthma defined by at least one of: overnight hospitalization for asthma in past 6 months OR two unscheduled clinic or emergency visits for asthma in past 12 months
- On long term controller medication for asthma OR asthma symptoms 3 or more days per week over past 2 weeks OR nighttime asthma symptoms at least 3 times in past month
- Exposure to cockroach indicated by trapping at least one cockroach in 3 days OR visual evidence by study staff
- Child sleeps in target home at least 4 nights per week on average
- Caregiver able to speak English or Spanish
You will not qualify if you...
- Other serious medical or chronic illnesses including chronic respiratory infections requiring daily medication
- Cardiovascular disease requiring daily medication (excluding hypertension)
- Taking a beta-blocker
- Current active smoker
- Currently receiving immunotherapy
- Plans to move within the 12 month follow-up period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tulane University
New Orleans, Louisiana, United States, 70112
Actively Recruiting
Research Team
D
Derek Werthmann, PhD
CONTACT
J
Joanna Baisier
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here